Table 1.
Top 50 differentially up- and down-regulated genome-wide genes and all different microRNAs between P-CSCs and Non-P-CSCs
| Gene Title | Gene Symbol | Log Ratio Case 1 | Log Ratio Case 2 | Gene Title | Gene Symbol | Log Ratio Case 1 | Log Ratio Case 2 |
|---|---|---|---|---|---|---|---|
| CD55 molecule | CD55 | 6.2 | 0.7 | cadherin 11, type 2, OB-cadherin | CDH11 | -8.9 | -0.6 |
| chromosome 1 open reading frame 119 | C1orf119 | 5.8 | 0.7 | glycoprotein M6B | GPM6B | -8.1 | -1.7 |
| Dystonin | DST | 5.4 | 1 | runt-related transcription factor | RUNX1T1 | -7.9 | -2.1 |
| matrix metallopeptidase 1 | MMP1 | 5.3 | 0.6 | nuclear factor I/B | NFIB | -7.8 | -3.5 |
| chitobiase, di-N-acetyl- | CTBS | 5.3 | 0.9 | purinergic receptor P2Y, G-protein coupled, 5 | P2RY5 | -7.5 | -3.1 |
| Mesothelin | MSLN | 5.1 | 0.6 | cadherin 10, type 2 | CDH10 | -7.4 | -0.8 |
| chromosome 17 open reading frame 91 | C17orf91 | 5 | 0.8 | GLI-Kruppel family member GLI3 | GLI3 | -7.4 | -1 |
| suppressor of cytokine signaling 4 | SOCS4 | 5 | 0.8 | Zic family member 4 | ZIC4 | -7.4 | -1.4 |
| junction plakoglobin | JUP | 4.9 | 0.6 | chromosome 7 open reading frame 4 | C7orf4 | -7.3 | -0.8 |
| ATP-binding cassette, sub-family C | ABCC3 | 4.9 | 0.8 | synaptonemal complex protein 1 | SYCP1 | -7 | -6 |
| occludin /// occludin pseudogene | LOC647859 | 4.9 | 0.6 | B-cell CLL/lymphoma 11B | BCL11B | -6.5 | -1.2 |
| selenoprotein P, plasma, 1 | SEPP1 | 4.8 | 0.7 | Boc homolog (mouse) | BOC | -6.4 | -1.1 |
| tetratricopeptide repeat domain 12 | TTC12 | 4.8 | 1.8 | ARP3 actin-related protein 3 homolog B pseudogene | LOC644773 | -6.4 | -4.5 |
| CDC14 cell division cycle 14 homolog B | CDC14B | 4.8 | 0.8 | LIM and senescent cell antigen-like domains 1 | LIMS1 | -6.3 | -1.3 |
| hypothetical protein FLJ31033 | FLJ31033 | 4.8 | 2.5 | zinc finger protein 423 | ZNF423 | -6.3 | -0.7 |
| jumonji, AT rich interactive domain 1B | JARID1B | 4.7 | 0.7 | hypothetical gene supported by BC037858 | LOC440117 | -6.2 | -1.2 |
| DnaJ (Hsp40) homolog, subfamily A, member 4 | DNAJA4 | 4.6 | 0.9 | eukaryotic translation initiation factor 5A | EIF5A | -6 | -1.5 |
| myosin VA (heavy chain 12, myoxin) | MYO5A | 4.6 | 0.6 | keratin associated protein 19-1 | KRTAP19-1 | -6 | -4.4 |
| protein inhibitor of activated STAT, 3 | PIAS3 | 4.5 | 0.7 | dermatopontin | DPT | -5.9 | -1.7 |
| interferon-induced protein with tetratricopeptide repeats 1 | IFIT1 | 4.5 | 0.8 | hypothetical protein LOC285419 | LOC285419 | -5.9 | -2.7 |
| pyruvate kinase, muscle | PKM2 | 4.4 | 1.9 | SEC14-like 4 | SEC14L4 | -5.9 | -2.8 |
| PQ loop repeat containing 3 | PQLC3 | 4.4 | 2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | ENPP2 | -5.7 | -2.6 |
| guanylate binding protein 3 | GBP3 | 4.3 | 0.7 | ropporin, rhophilin associated protein 1 | ROPN1 | -5.7 | -1.1 |
| cytochrome P450, family 4, subfamily X, polypeptide 1 | CYP4X1 | 4.3 | 0.8 | chromosome 5 open reading frame 13 | C5orf13 | -5.6 | -0.6 |
| O-linked N-acetylglucosamine (GlcNAc) transferase | OGT | 4.2 | 0.7 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | ATP6V0D2 | -5.5 | -1.1 |
| hsa-miR-590-3p | 2.49 | 2.35 | hsa-miR-146b-3p | -2.40 | -3.00 | ||
| hsa-miR-20a* | 1.28 | 1.35 | hsa-miR-575 | -1.57 | -1.70 | ||
| hsa-miR-142-3p | 0.92 | 1.66 | hsa-miR-647 | -1.21 | -2.30 | ||
| hsa-miR-424 | 0.75 | 1.20 | hsa-miR-638 | -1.05 | -0.69 | ||
| hsa-miR-29a* | 0.66 | 1.20 | hsa-miR-494 | -0.97 | -0.79 | ||
| hsa-miR-135b | 0.65 | 1.11 | hsa-miR-939 | -0.83 | -1.11 | ||
| hsa-miR-141* | 0.60 | 1.50 | hsa-miR-1226* | -0.76 | -1.07 | ||
| hsa-miR-423-3p | -0.70 | -1.75 |